131I-IPA and Concurrent XRT in Recurrent GBM

NCT03849105 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Telix Pharmaceuticals (Innovations) Pty Limited